The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain ...
Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.
Posay's Effaclar Duo acne treatment over concerns of benzene contamination, a known carcinogen. But skin experts say you ...
Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing carcinogen contamination.
Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.
The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.
Popular skincare brands are issuing a recall on items sold at retailers including Walgreens and Target over a cancer-linked ingredient.
Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...
1d
Investor's Business Daily on MSNRoche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 BillionRoche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.
A restaurant in the Brâncovenesc Salon of the Palace of Parliament was closed on Thursday, March 13, by inspectors from the ...
Shares of weight loss drug developers gained on Wednesday after Roche (OTCQX:RHHBF) announced a multi-billion-dollar deal ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results